These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21531792)

  • 1. Therapeutic effects on atopic dermatitis by anti-RelA short interfering RNA combined with functional peptides Tat and AT1002.
    Uchida T; Kanazawa T; Kawai M; Takashima Y; Okada H
    J Pharmacol Exp Ther; 2011 Aug; 338(2):443-50. PubMed ID: 21531792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of an efficient transdermal delivery system of small interfering RNA using functional peptides, Tat and AT-1002.
    Uchida T; Kanazawa T; Takashima Y; Okada H
    Chem Pharm Bull (Tokyo); 2011; 59(2):196-201. PubMed ID: 21297299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-RelA siRNA-Encapsulated Flexible Liposome with Tight Junction-Opening Peptide as a Non-invasive Topical Therapeutic for Atopic Dermatitis.
    Ibaraki H; Kanazawa T; Kurano T; Oogi C; Takashima Y; Seta Y
    Biol Pharm Bull; 2019; 42(7):1216-1225. PubMed ID: 31257297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal anti-nuclear kappaB siRNA therapy for atopic dermatitis using a combination of two kinds of functional oligopeptide.
    Ibaraki H; Kanazawa T; Takashima Y; Okada H; Seta Y
    Int J Pharm; 2018 May; 542(1-2):213-220. PubMed ID: 29551748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a Liquid Crystal Formulation that Can Penetrate the Stratum Corneum for Intradermal Delivery of Small Interfering RNA.
    Kawai M; Ibaraki H; Takashima Y; Kanazawa T; Okada H
    Mol Pharm; 2021 Mar; 18(3):1038-1047. PubMed ID: 33395310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional peptide nanocarriers for delivery of novel anti-RelA RNA interference agents as a topical treatment of atopic dermatitis.
    Kanazawa T; Hamasaki T; Endo T; Tamano K; Sogabe K; Seta Y; Ohgi T; Okada H
    Int J Pharm; 2015 Jul; 489(1-2):261-7. PubMed ID: 25956048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive delivery of siRNA into the epidermis by iontophoresis using an atopic dermatitis-like model rat.
    Kigasawa K; Kajimoto K; Hama S; Saito A; Kanamura K; Kogure K
    Int J Pharm; 2010 Jan; 383(1-2):157-60. PubMed ID: 19732811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of scratching behavior by silencing an endogenous cyclooxygenase-1 gene in the skin through the administration of siRNA.
    Inoue T; Sugimoto M; Sakurai T; Saito R; Futaki N; Hashimoto Y; Honma Y; Arai I; Nakaike S
    J Gene Med; 2007 Nov; 9(11):994-1001. PubMed ID: 17703497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of an Innovative Intradermal siRNA Delivery System Using a Combination of a Functional Stearylated Cytoplasm-Responsive Peptide and a Tight Junction-Opening Peptide.
    Ibaraki H; Kanazawa T; Takashima Y; Okada H; Seta Y
    Molecules; 2016 Sep; 21(10):. PubMed ID: 27669207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigallocatechin-3-gallate improves Dermatophagoides pteronissinus extract-induced atopic dermatitis-like skin lesions in NC/Nga mice by suppressing macrophage migration inhibitory factor.
    Noh SU; Cho EA; Kim HO; Park YM
    Int Immunopharmacol; 2008 Sep; 8(9):1172-82. PubMed ID: 18602062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of topically applied Korean red ginseng and its genuine constituents on atopic dermatitis-like skin lesions in NC/Nga mice.
    Kim HS; Kim DH; Kim BK; Yoon SK; Kim MH; Lee JY; Kim HO; Park YM
    Int Immunopharmacol; 2011 Feb; 11(2):280-5. PubMed ID: 21118672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pep-1 peptide-conjugated elastic liposomal formulation of taxifolin glycoside for the treatment of atopic dermatitis in NC/Nga mice.
    Kang MJ; Eum JY; Park SH; Kang MH; Park KH; Choi SE; Lee MW; Kang KH; Oh CH; Choi YW
    Int J Pharm; 2010 Dec; 402(1-2):198-204. PubMed ID: 20888893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of tumor growth by systemic delivery of anti-VEGF siRNA with cell-penetrating peptide-modified MPEG-PCL nanomicelles.
    Kanazawa T; Sugawara K; Tanaka K; Horiuchi S; Takashima Y; Okada H
    Eur J Pharm Biopharm; 2012 Aug; 81(3):470-7. PubMed ID: 22579732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A hypothetical mechanism of intraepidermal neurite formation in NC/Nga mice with atopic dermatitis.
    Tominaga M; Ozawa S; Ogawa H; Takamori K
    J Dermatol Sci; 2007 Jun; 46(3):199-210. PubMed ID: 17350228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of an atopic dermatitis-like skin model in a hairless mouse by repeated elicitation of contact hypersensitivity that enables to conduct functional analyses of the stratum corneum with various non-invasive biophysical instruments.
    Matsumoto K; Mizukoshi K; Oyobikawa M; Ohshima H; Tagami H
    Skin Res Technol; 2004 May; 10(2):122-9. PubMed ID: 15059180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effects of streptococcal preparation OK-432 on atopic dermatitis-like lesions in NC/Nga mice: possible shift from a Th2- to Th1-predominance.
    Horiuchi Y; Bae S; Katayama I; Nishioka K
    J Dermatol Sci; 2004 Sep; 35(3):187-97. PubMed ID: 15381240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of dermatitis by iontophoretically delivered antisense oligonucleotides for interleukin-10 in NC/Nga mice.
    Sakamoto T; Miyazaki E; Aramaki Y; Arima H; Takahashi M; Kato Y; Koga M; Tsuchiya S
    Gene Ther; 2004 Feb; 11(3):317-24. PubMed ID: 14737092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperresponsive TH2 cells with enhanced nuclear factor-kappa B activation induce atopic dermatitis-like skin lesions in Nishiki-nezumi Cinnamon/Nagoya mice.
    Tenda Y; Yamashita M; Kimura MY; Hasegawa A; Shimizu C; Kitajima M; Onodera A; Suzuki A; Seki N; Nakayama T
    J Allergy Clin Immunol; 2006 Sep; 118(3):725-33. PubMed ID: 16950294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Objective evaluation of the efficacy of daily topical applications of cosmetics bases using the hairless mouse model of atopic dermatitis.
    Matsumoto K; Mizukoshi K; Oyobikawa M; Ohshima H; Sakai Y; Tagami H
    Skin Res Technol; 2005 Aug; 11(3):209-17. PubMed ID: 15998334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical application of a novel ceramide derivative, K6PC-9, inhibits dust mite extract-induced atopic dermatitis-like skin lesions in NC/Nga mice.
    Kang JS; Youm JK; Jeong SK; Park BD; Yoon WK; Han MH; Lee H; Han SB; Lee K; Park SK; Lee SH; Yang KH; Moon EY; Kim HM
    Int Immunopharmacol; 2007 Dec; 7(13):1589-97. PubMed ID: 17996668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.